Dissertation > Excellent graduate degree dissertation topics show

Preparation and Immune Protection of the Recombinant VP2Protein of IBDV

Author: XieHuaiDong
Tutor: FanHongJie
School: Nanjing Agricultural College
Course: Veterinary
Keywords: infectious bursal disease virus(IBDV) the recombinant Vp2protein genetical engineering vaccine immune protective test
CLC: S852.4
Type: Master's thesis
Year: 2012
Downloads: 28
Quote: 0
Read: Download Dissertation


Infectious bursal disease (IBD) is one of the major infectious disease, which may cause serious economic loss both in our country and throughout the world. Now, there were security and manufacture defects in common ambly-toxicum vaccine and inactive vaccines, and much biosafety problems existing in the middle hadro-virulent live vaccines when applyed to protecting variational strain. So in practice, it is badly needed to develop a neotype IBD genetically engineering vaccine with better immune validity and biosafety, and even directly to the current popular strain. Two parts were content in this thesis:Expl. Preparation of the recombinant Vp2protein of infectious bursal disease virusThe efficiently expressed IBDV Vp2restructuring baculovirus vBacA-Vp2(P3generation) constructed in our laboratory in the early days were used to vaccinate the Sf9cells. After that the Sf9cells infected with rBacA-Vp2were stained positively against IBDV antibody using the indirect immunofluorescence assay (IFA). The IBDV antibody sandwich ELISA results showed positive reaction. Western blotting showed that the calculated protein of approximately53ku was in the expressed in the insect cells. Moreover, virus-like particles (VLPs) structure in the infected Sf9cells was observed under electron microscopy. The recombinant Vp2protein was self-assemblyed into virus-like particals. Our experiment provided the backgrounds of neotype virus-like partical vaccine and detective reagent researching directly at the recent prevalent IBDV. The Vp2protein expression condition optimized and Sf9cells pre-layed one day before intfection, vBacA-Vp2with multiple infections was vaccinated until the cell density reaching90%. Then cell culture was collected at72,96and120h respectly, the IBDV double-antibody sandwich ELISA technique was used to determine the antibody titer of the culture. Results indicated that the multiply of infection immunized with vBacA-Vp2was0.01, at the expression time point of 72h, and the recombinant Vp2protein content in the cell culture was the highest with the antigen titer upto3.2×103. Then the optimized culture condition of the recombinant Vp2pretein was used to vaccinate vBacA-Vp2, collecting the cell cultures, a great mass of the recombinant Vp2protein was produced, and to prepare the antigen for new and high efficient IBD virus-like particles genetical engineering vaccine.Exp II. Immune protection of the recombinant Vp2protein of infectious bursal disease virusThe lysate of Sf9insect cell infected by the recombinant baculovirus vBacA-Vp2was emulsificated with ISA206, ISA50and whte oil respectly, made into antigen and used to immunize2-week old SPF chicken,14days post primary immunization, the level of enzyme linked immunosorbent assay (ELISA) antibody titers of chicken immunized by the recombinant IBDV Vp2protein plused with ISA206and B87vaccine groups were significantly higher than others (ISA50, white oil and blank control groups)(P<0.01). However, no obvious difference was found between ISA206and B87groups (P>0.05).14days post the second immunization, the level of enzyme linked immunosorbent assay (ELISA) antibody in the group immunized by the recombinant Vp2protein plus ISA206immunologic adjuvant was significantly higher than other3groups (B87, ISA50and blank control groups)(P<0.01), while no obvious difference was observered among the chicken immuned with the traditional B87vaccine and the recombinant Vp2protein plus white oil and ISA50(P>0.05). Compared with other groups (B87, ISA50, white oil and blank control groups), the results of neutralizing antibody titer assay showed that the neutralizing antibody titer in ISA206group significantly increased (P<0.01). After challenging, chicken in ISA206, white oil and B87vaccine groups were all alived with a survival rate of100%, while the rate was80%in chicken protected by the recombinant Vp2protein plus ISA50immunologic adjuvant, and the ckicken in the blank control group were all died. During the7days observation, no clinical symptom and pathological change were found in the ckicken protected by the recombinant Vp2protein plus ISA206and white oil immunization. It was concluded that the IBD virus-liked particles subunit vaccine prepared by the recombinant Vp2protein showed an important application prospect on the researching in new type IBD genetical engineering vaccine.

Related Dissertations

  1. The Development of A Novel Vaccine Strain of Infectious Bursal Disease Virus Using Reverse Genetics,S852.65
  2. The Construction of Plasmids Containing IBDV VP2/4/3 and ChIL-18 Fusion and Co-expression Genes as Well as the Study on Their Immunogenicity,S852.5
  3. Molecular Analysis, Expression and Application of VP2 Gene of Infectious Bursal Disease Virus,S852.65
  4. Development of Assays for Detection Infectious Bursal Disease Virus,S858.31
  5. Preparation of Monoclonal Antibodies Against IBDV and Sequence Analysis of VP2 Gene,S852.65
  6. Construction of a cDNA Library of Chicken Embryo Fibroblast and Preparation of the Monoclonal Antibody that Can Inhibit Infectious Bursal Disease Virus Infection,S858.31
  7. Expression of Recombinant Plasmids Containing IBDV VP2/4/3 and ChIL-2 Fusion Genes in Eukaryotic Cells and Experimental Application,S852.65
  8. Construction of Universal Transfer Vector Marek’s Disease Virus Vaccine Strain CVI988/Rispens and Development of Recombinant MDV Expressing the VP2 Gene of Infectious Bursal Disease Virus,S852.65
  9. Sequencing and Phelogenetic Analysis of Hypervariable Region of Infectious Bursal Disease Virus VP2 Gene,S852.65
  10. Extraction of Rice Bran Polysaccharide and Its Effects on Modulating Immune Function of Chickens Infected with IBDV,S858.31
  11. Development and Primary Application of Hybridoma Cell Lines Respectively Secreting Monoclonal Antibodies Against Infectious Bursal Disease Virus and Lipopolysa Ccharide of Shigellae in the Chichen,S854.43
  12. Construction of A Chicken B Cell cDNA Library Displayed on Phage T7 and Identification of B Cell Receptor for Infectious Bursal Disease Virus (IBDV),S852.4
  13. Complete Genomic Cloning and Development in the Reverse Genetics System for Infectious Bursal Disease Virus,R346
  14. Expression of Infectious Bursal Disease Virus (IBDV) Polyprotein in Bombyx Mori and the Study of Its Immunogenicity,S852.4
  15. Complete Genomic Cloning and Development in the Reverse Genetics System for IBDV B87 Strain,S852.65
  16. SAGE Transcript Profiles of Vero Cells Infected by Infectious Bursal Disease Virus (IBDV), and Transformed with Genes Encoded by IBDV A-Segment,S852.65
  17. The Development of the Reverse-genetics System and Gene-function Research for Infectious Bursal Disease Virus,S852.65
  18. Evolutionary Trace Analysis of the Precursor Polyprotein Encoded by the Genome Segment a of Infectious Bursal Disease Virus,S852.65
  19. The Study on Chicken Toll-Like Receptors,S852.4
  20. Construction and Immune Responses of the Tandemed Gene of Infectious Bursal Disease Virus VP2and Chicken Complement C3D,S858.31
  21. Isolation and Identification of Two Very Virulent Infectious Bursal Disease Virus Strains with Natural Reassortment Characteristic and Expression of the Clonied Genes VP2and VP3in E. Coli,S852.65

CLC: > Agricultural Sciences > Livestock, animal medicine,hunting,silkworm,bee > Animal Medicine ( Veterinary Medicine) > Basic Veterinary Science > Animal Immunology
© 2012 www.DissertationTopic.Net  Mobile